Evidence map›Paper›PMID 19923465›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

The Tpl2 mutation Sluggish impairs type I IFN production and increases susceptibility to group B streptococcal disease.

Nengming Xiao, Celine Eidenschenk, Philippe Krebs, Katharina Brandl, Amanda L Blasius, Yu Xia, Kevin Khovananth, Nora G Smart, Bruce Beutler

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. HCFC2 is needed for IRF1- and IRF2-dependentThe Journal of experimental medicine · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nengming XiaoDepartment of Genetics, The Scripps Research Institute, La Jolla, CA 92037, USA.
Celine Eidenschenk
Philippe Krebs
Katharina Brandl
Amanda L Blasius
Yu Xia
Kevin Khovananth
Nora G Smart
Bruce Beutler
Scripps Research Institute · US

Funding

Sequencing CoreP01AI070167 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI BEUTLER, BRUCE A · 2006 to 2016
$27.2M
TLR4 AS AN LPS SENSOR AND SUSCEPTIBILITY LOCUSR01GM060031 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI BEUTLER, BRUCE A · 2000 to 2007
$4.5M
NIAID NIH HHS 5P01AI070167NIAID NIH HHS HHSN272200700038CNIAID NIH HHS P01 AI070167NIGMS NIH HHS R01 GM060031
6 · The paper itself

Abstract

Sluggish was identified in a population of third generation mice descended from N-ethyl-N-nitrosourea-mutagenized sires. Macrophages from homozygotes exhibited impaired TNF-alpha production in response to all TLR ligands tested and displayed impaired type I IFN production in response to TLR7 and TLR9 stimulations. The phenotype was confined to a critical region on mouse chromosome 18 and then ascribed to a T to A transversion in the acceptor splice site of intron 4 at position 13346 of the Map3k8 gene, resulting in defective splicing. The Map3k8(Sluggish) mutation does not result in susceptibility to viral infections, but Sluggish mice displayed high susceptibility to group B streptococcus infection, with impaired TNF-alpha and type I IFN production in infected macrophages. Our data demonstrate that the encoded protein kinase Tpl2 plays an essential role in cell signaling in the immune response to certain pathogens.

Indexed as

EthylnitrosoureaGenetic Predisposition to DiseaseMutagenesisAnimalsHerpesviridae InfectionsInterferon Type IListeriosisMaleMAP Kinase Kinase KinasesMiceMice, Inbred C3HMice, Inbred C57BLMice, KnockoutMice, TransgenicMuromegalovirusProto-Oncogene ProteinsEthylnitrosoureaInterferon Type IMap3k8 protein, mouseMAP Kinase Kinase KinasesProto-Oncogene Proteins

Identifiers

PMID19923465
PMCPMC8424661
OpenAlexW1549643265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.